222 related articles for article (PubMed ID: 21714923)
1. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial.
Smart-Halajko MC; Kelley-Hedgepeth A; Montefusco MC; Cooper JA; Kopin A; McCaffrey JM; Balasubramanyam A; Pownall HJ; Nathan DM; Peter I; Talmud PJ; Huggins GS;
BMC Med Genet; 2011 Jun; 12():89. PubMed ID: 21714923
[TBL] [Abstract][Full Text] [Related]
2. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population.
Abid K; Trimeche T; Mili D; Msolli MA; Trabelsi I; Nouira S; Kenani A
Lipids Health Dis; 2016 Mar; 15():63. PubMed ID: 27004807
[TBL] [Abstract][Full Text] [Related]
3. ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk.
Talmud PJ; Smart M; Presswood E; Cooper JA; Nicaud V; Drenos F; Palmen J; Marmot MG; Boekholdt SM; Wareham NJ; Khaw KT; Kumari M; Humphries SE; ;
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2319-25. PubMed ID: 18974381
[TBL] [Abstract][Full Text] [Related]
4. Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.
Dewey FE; Gusarova V; O'Dushlaine C; Gottesman O; Trejos J; Hunt C; Van Hout CV; Habegger L; Buckler D; Lai KM; Leader JB; Murray MF; Ritchie MD; Kirchner HL; Ledbetter DH; Penn J; Lopez A; Borecki IB; Overton JD; Reid JG; Carey DJ; Murphy AJ; Yancopoulos GD; Baras A; Gromada J; Shuldiner AR
N Engl J Med; 2016 Mar; 374(12):1123-33. PubMed ID: 26933753
[TBL] [Abstract][Full Text] [Related]
5. Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
Gagnon E; Bourgault J; Gobeil É; Thériault S; Arsenault BJ
Atherosclerosis; 2024 Jun; 393():117558. PubMed ID: 38703417
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate intake modifies associations between ANGPTL4[E40K] genotype and HDL-cholesterol concentrations in White men from the Atherosclerosis Risk in Communities (ARIC) study.
Nettleton JA; Volcik KA; Hoogeveen RC; Boerwinkle E
Atherosclerosis; 2009 Mar; 203(1):214-20. PubMed ID: 18599063
[TBL] [Abstract][Full Text] [Related]
7. The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk.
Smart-Halajko MC; Robciuc MR; Cooper JA; Jauhiainen M; Kumari M; Kivimaki M; Khaw KT; Boekholdt SM; Wareham NJ; Gaunt TR; Day IN; Braund PS; Nelson CP; Hall AS; Samani NJ; Humphries SE; Ehnholm C; Talmud PJ
Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2277-82. PubMed ID: 20829508
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in triglycerides according to ANGPTL4[E40K] genotype and longitudinal body weight change in the atherosclerosis risk in communities study.
Nettleton JA; Volcik KA; Demerath EW; Boerwinkle E; Folsom AR
Ann Epidemiol; 2008 Nov; 18(11):842-6. PubMed ID: 18809343
[TBL] [Abstract][Full Text] [Related]
9. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
; Stitziel NO; Stirrups KE; Masca NG; Erdmann J; Ferrario PG; König IR; Weeke PE; Webb TR; Auer PL; Schick UM; Lu Y; Zhang H; Dube MP; Goel A; Farrall M; Peloso GM; Won HH; Do R; van Iperen E; Kanoni S; Kruppa J; Mahajan A; Scott RA; Willenberg C; Braund PS; van Capelleveen JC; Doney AS; Donnelly LA; Asselta R; Merlini PA; Duga S; Marziliano N; Denny JC; Shaffer CM; El-Mokhtari NE; Franke A; Gottesman O; Heilmann S; Hengstenberg C; Hoffman P; Holmen OL; Hveem K; Jansson JH; Jöckel KH; Kessler T; Kriebel J; Laugwitz KL; Marouli E; Martinelli N; McCarthy MI; Van Zuydam NR; Meisinger C; Esko T; Mihailov E; Escher SA; Alver M; Moebus S; Morris AD; Müller-Nurasyid M; Nikpay M; Olivieri O; Lemieux Perreault LP; AlQarawi A; Robertson NR; Akinsanya KO; Reilly DF; Vogt TF; Yin W; Asselbergs FW; Kooperberg C; Jackson RD; Stahl E; Strauch K; Varga TV; Waldenberger M; Zeng L; Kraja AT; Liu C; Ehret GB; Newton-Cheh C; Chasman DI; Chowdhury R; Ferrario M; Ford I; Jukema JW; Kee F; Kuulasmaa K; Nordestgaard BG; Perola M; Saleheen D; Sattar N; Surendran P; Tregouet D; Young R; Howson JM; Butterworth AS; Danesh J; Ardissino D; Bottinger EP; Erbel R; Franks PW; Girelli D; Hall AS; Hovingh GK; Kastrati A; Lieb W; Meitinger T; Kraus WE; Shah SH; McPherson R; Orho-Melander M; Melander O; Metspalu A; Palmer CN; Peters A; Rader D; Reilly MP; Loos RJ; Reiner AP; Roden DM; Tardif JC; Thompson JR; Wareham NJ; Watkins H; Willer CJ; Kathiresan S; Deloukas P; Samani NJ; Schunkert H
N Engl J Med; 2016 Mar; 374(12):1134-44. PubMed ID: 26934567
[TBL] [Abstract][Full Text] [Related]
10. Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study.
Huggins GS; Papandonatos GD; Erar B; Belalcazar LM; Brautbar A; Ballantyne C; Kitabchi AE; Wagenknecht LE; Knowler WC; Pownall HJ; Wing RR; Peter I; McCaffery JM;
Circ Cardiovasc Genet; 2013 Aug; 6(4):391-9. PubMed ID: 23861364
[TBL] [Abstract][Full Text] [Related]
11. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
Romeo S; Pennacchio LA; Fu Y; Boerwinkle E; Tybjaerg-Hansen A; Hobbs HH; Cohen JC
Nat Genet; 2007 Apr; 39(4):513-6. PubMed ID: 17322881
[TBL] [Abstract][Full Text] [Related]
12. ANGPTL4 gene E40K variation protects against obesity-associated dyslipidemia in participants with obesity.
Bailetti D; Bertoccini L; Mancina RM; Barchetta I; Capoccia D; Cossu E; Pujia A; Lenzi A; Leonetti F; Cavallo MG; Romeo S; Baroni MG
Obes Sci Pract; 2019 Feb; 5(1):83-90. PubMed ID: 30820332
[TBL] [Abstract][Full Text] [Related]
13. Association of a genetic variant in the angiopoietin-like protein 4 gene with metabolic syndrome.
Kharazmi-Khorassani S; Kharazmi-Khorassani J; Rastegar-Moghadam A; Samadi S; Ghazizadeh H; Tayefi M; Ferns GA; Ghayour-Mobarhan M; Avan A; Esmaily H
BMC Med Genet; 2019 Jun; 20(1):97. PubMed ID: 31164103
[TBL] [Abstract][Full Text] [Related]
14. Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial.
Peter I; McCaffery JM; Kelley-Hedgepeth A; Hakonarson H; Reis S; Wagenknecht LE; Kopin AS; Huggins GS;
Obesity (Silver Spring); 2012 Aug; 20(8):1675-82. PubMed ID: 22307069
[TBL] [Abstract][Full Text] [Related]
15. Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.
Gusarova V; O'Dushlaine C; Teslovich TM; Benotti PN; Mirshahi T; Gottesman O; Van Hout CV; Murray MF; Mahajan A; Nielsen JB; Fritsche L; Wulff AB; Gudbjartsson DF; Sjögren M; Emdin CA; Scott RA; Lee WJ; Small A; Kwee LC; Dwivedi OP; Prasad RB; Bruse S; Lopez AE; Penn J; Marcketta A; Leader JB; Still CD; Kirchner HL; Mirshahi UL; Wardeh AH; Hartle CM; Habegger L; Fetterolf SN; Tusie-Luna T; Morris AP; Holm H; Steinthorsdottir V; Sulem P; Thorsteinsdottir U; Rotter JI; Chuang LM; Damrauer S; Birtwell D; Brummett CM; Khera AV; Natarajan P; Orho-Melander M; Flannick J; Lotta LA; Willer CJ; Holmen OL; Ritchie MD; Ledbetter DH; Murphy AJ; Borecki IB; Reid JG; Overton JD; Hansson O; Groop L; Shah SH; Kraus WE; Rader DJ; Chen YI; Hveem K; Wareham NJ; Kathiresan S; Melander O; Stefansson K; Nordestgaard BG; Tybjærg-Hansen A; Abecasis GR; Altshuler D; Florez JC; Boehnke M; McCarthy MI; Yancopoulos GD; Carey DJ; Shuldiner AR; Baras A; Dewey FE; Gromada J
Nat Commun; 2018 Jun; 9(1):2252. PubMed ID: 29899519
[TBL] [Abstract][Full Text] [Related]
16. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
Miida T; Hirayama S
Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.
Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Roell WC; Konrad RJ
Biochem Biophys Res Commun; 2021 Jan; 534():498-503. PubMed ID: 33239171
[TBL] [Abstract][Full Text] [Related]
18. Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice.
Adachi H; Kondo T; Koh GY; Nagy A; Oike Y; Araki E
Biochem Biophys Res Commun; 2011 Jun; 409(2):177-80. PubMed ID: 21549101
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.
Palmer CN; Maglio C; Pirazzi C; Burza MA; Adiels M; Burch L; Donnelly LA; Colhoun H; Doney AS; Dillon JF; Pearson ER; McCarthy M; Hattersley AT; Frayling T; Morris AD; Peltonen M; Svensson PA; Jacobson P; Borén J; Sjöström L; Carlsson LM; Romeo S
PLoS One; 2012; 7(6):e39362. PubMed ID: 22724004
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients.
Muendlein A; Saely CH; Leiherer A; Fraunberger P; Kinz E; Rein P; Vonbank A; Zanolin D; Malin C; Drexel H
Atherosclerosis; 2014 Dec; 237(2):632-8. PubMed ID: 25463098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
